The Middle East & Africa Allergy immunotherapies market was valued at US$ 137.87 million in 2019 and is projected to reach US$ 297.62 million by 2027; it is expected to grow at a CAGR of 10.2% during the forecast period.
The increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations are the key factors fueling the allergy immunotherapies market growth.
Allergen immunotherapy is a medical treatment useful for environmental allergies, insect bite allergies, and asthma. This involves the regular administration of gradually increasing the dose of allergen extracts into the patient’s body over a certain period. The Allergy Immunotherapy market in the Middle East and Africa region is expected to exhibit the highest growth rate due to the increased incidence of allergy people in developing countries like Saudi Arabia and South Africa. In the recent report of the National Health and Nutrition Examination Survey, 54% of the population had positive test responses to one or more allergens. Allergic disorders are mostly treated with immunotherapy; thus, the growing prevalence of allergic diseases drives the growth of the market. Also, the growing unmet needs of novel targeted drugs, which are used to treat the allergic conditions, will create growth opportunities for the market players. Many companies are investing in research and development to develop targeted drugs for various allergic disorders.
The Covid-19 pandemic has harmed Middle East and Africa allergy immunotherapies market size, with small and medium scale companies struggling to sustain their businesses in the near-term future. Industry leaders are now focusing on creating new business practices to deal with crises like Covid-19 pandemic.
Middle East and Africa Allergy Immunotherapies Market Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
MIDDLE EAST AND AFRICA ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION
By Treatment
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
By Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Company Profiles
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment and Sublingual Immunotherapy , Allergy type, Distribution Channel and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Saudi Arabia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Allergy Immunotherapies Market – By Treatment
1.3.2 Middle East and Africa Allergy Immunotherapies Market – By Allergy Type
1.3.3 Middle East and Africa Allergy Immunotherapies Market – By Distribution Channel
1.3.4 Middle East and Africa Allergy Immunotherapies Market – By Geography
2. Allergy Immunotherapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Allergy Immunotherapies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa (MEA) – PEST Analysis
4.3 Expert Opinion
5. Allergy immunotherapies Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Presence of Strong Product Pipeline
5.4 Future Trends
5.4.1 Increasing FDA Approvals for Drugs
5.5 Impact Analysi
6. Allergy Immunotherapies Market – Middle East and Africa Analysis
6.1 Middle East and Africa Allergy Immunotherapies Market Revenue Forecast and Analysis
7. Allergy Immunotherapies Market Analysis– by Treatment
7.1 Overview
7.2 Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.3.2 Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
8. Allergy Immunotherapies Market Analysis– by Allergy Type
8.1 Overview
8.2 Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. Allergy Immunotherapies Market Analysis– by Distribution Channel
9.1 Overview
9.2 Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
10. Allergy Immunotherapies Market Analysis and Forecasts To 2027 – Geographical Analysis
10.1 Middle East & Africa: Allergy immunotherapies market
10.1.1 Overview
10.1.2 Middle East & Africa: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.1.7 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 South Africa: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Middle East and Africa Allergy Immunotherapies Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 ALK-Abelló A/S
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AIMMUNE THERAPEUTICS, INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Stallergenes Greer
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 HAL Allergy B.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson and Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Anergis
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 DBV Technologies
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Allergy Therapeutics
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 3. Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 4. Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 5. Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million
Table 8. UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 9. UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 11. South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Allergy Immunotherapies Market
LIST OF FIGURES
Figure 1. Allergy Immunotherapies Market Segmentation
Figure 2. Allergy Immunotherapies Market – By Geography
Figure 3. Middle East and Africa Allergy Immunotherapies Market Overview
Figure 4. Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market
Figure 5. Middle East and Africa Allergy Immunotherapies Market- Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa (MEA) PEST Analysis
Figure 7. Allergy immunotherapies Market Impact Analysis of Driver and Restraints
Figure 8. Middle East and Africa Allergy Immunotherapies Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)
Figure 10. Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 11. Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 12. Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)
Figure 13. Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
Figure 14. Asthma Market Revenue and Forecasts to 2027 (US$ Million)
Figure 15. Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 16. Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 17. Others Market Revenue and Forecasts to 2027 (US$ Million)
Figure 18. Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)
Figure 19. Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 20. Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 21. Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 22. Middle East & Africa: Allergy immunotherapies market, by Key Country – Revenue (2019) (USD Million)
Figure 23. Middle East & Africa Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 24. Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 25. Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 26. UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 27. South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic on allergy immunotherapies market in Middle East and Africa
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Middle East and Africa Allergy Immunotherapies Market
Nov 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Nov 2020